These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 33563655)

  • 1. Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept.
    Davis GM; Faulds E; Walker T; Vigliotti D; Rabinovich M; Hester J; Peng L; McLean B; Hannon P; Poindexter N; Saunders P; Perez-Guzman C; Tekwani SS; Martin GS; Umpierrez G; Agarwal S; Dungan K; Pasquel FJ
    Diabetes Care; 2021 Apr; 44(4):1055-1058. PubMed ID: 33563655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.
    Sadhu AR; Serrano IA; Xu J; Nisar T; Lucier J; Pandya AR; Patham B
    J Diabetes Sci Technol; 2020 Nov; 14(6):1065-1073. PubMed ID: 33063556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study.
    Faulds ER; Boutsicaris A; Sumner L; Jones L; McNett M; Smetana KS; May CC; Buschur E; Exline MC; Ringel MD; Dungan K
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4007-e4016. PubMed ID: 34100545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic.
    Agarwal S; Mathew J; Davis GM; Shephardson A; Levine A; Louard R; Urrutia A; Perez-Guzman C; Umpierrez GE; Peng L; Pasquel FJ
    Diabetes Care; 2021 Mar; 44(3):847-849. PubMed ID: 33361145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit.
    Ang L; Lin YK; Schroeder LF; Huang Y; DeGeorge CA; Arnold P; Akanbi F; Knotts S; DuBois E; Desbrough N; Qu Y; Freeman R; Esfandiari NH; Pop-Busui R; Gianchandani R
    J Diabetes Sci Technol; 2024 May; 18(3):562-569. PubMed ID: 38563491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study.
    Boeder S; Kobayashi E; Ramesh G; Serences B; Kulasa K; Majithia AR
    J Diabetes Sci Technol; 2023 May; 17(3):642-648. PubMed ID: 35876258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Continuous Glucose Monitoring to Assess Parenteral Nutrition-Induced Hyperglycemia in an Adult Patient With Severe COVID-19.
    Chow KW; Kelly DJ; Gupta R; Miller JD
    JPEN J Parenter Enteral Nutr; 2021 Jan; 45(1):208-211. PubMed ID: 33085780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19.
    Faulds ER; Jones L; McNett M; Smetana KS; May CC; Sumner L; Buschur E; Exline M; Ringel MD; Dungan K
    Endocr Pract; 2021 Apr; 27(4):354-361. PubMed ID: 33515756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU.
    Chow KW; Kelly DJ; Rieff MC; Skala PA; Kravets I; Charitou MM; Morley EJ; Gupta R; Miller JD
    J Diabetes Sci Technol; 2021 May; 15(3):607-614. PubMed ID: 33435706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial.
    Boom DT; Sechterberger MK; Rijkenberg S; Kreder S; Bosman RJ; Wester JP; van Stijn I; DeVries JH; van der Voort PH
    Crit Care; 2014 Aug; 18(4):453. PubMed ID: 25139609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring in the Intensive Care Unit.
    Guerrero-Arroyo L; Faulds E; Perez-Guzman MC; Davis GM; Dungan K; Pasquel FJ
    J Diabetes Sci Technol; 2023 May; 17(3):667-678. PubMed ID: 37081830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic.
    Galindo RJ; Aleppo G; Klonoff DC; Spanakis EK; Agarwal S; Vellanki P; Olson DE; Umpierrez GE; Davis GM; Pasquel FJ
    J Diabetes Sci Technol; 2020 Jul; 14(4):822-832. PubMed ID: 32536205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial.
    Klarskov CK; Windum NA; Olsen MT; Dungu AM; Jensen AK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Diabetes Technol Ther; 2022 Feb; 24(2):102-112. PubMed ID: 34524009
    [No Abstract]   [Full Text] [Related]  

  • 15. Complexity of continuous glucose monitoring data in critically ill patients: continuous glucose monitoring devices, sensor locations, and detrended fluctuation analysis methods.
    Signal M; Thomas F; Shaw GM; Chase JG
    J Diabetes Sci Technol; 2013 Nov; 7(6):1492-506. PubMed ID: 24351175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a hybrid protocol using continuous glucose monitoring and point-of-care testing in non-critically ill patients in a community hospital.
    Baker M; Lauterwasser S; Valenti C; Kallenberger M; Stolte H
    Am J Health Syst Pharm; 2024 Apr; 81(9):e261-e267. PubMed ID: 38146957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unified Hyperglycemia and Diabetic ketoacidosis (DKA) insulin infusion protocol based on an Excel algorithm and implemented via Electronic Medical Record (EMR) in Intensive Care Units.
    Gupta D; Kirn M; Jamkhana ZA; Lee R; Albert SG; Rollins KM
    Diabetes Metab Syndr; 2017; 11(4):265-271. PubMed ID: 27658894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.
    Galindo RJ; Umpierrez GE; Rushakoff RJ; Basu A; Lohnes S; Nichols JH; Spanakis EK; Espinoza J; Palermo NE; Awadjie DG; Bak L; Buckingham B; Cook CB; Freckmann G; Heinemann L; Hovorka R; Mathioudakis N; Newman T; O'Neal DN; Rickert M; Sacks DB; Seley JJ; Wallia A; Shang T; Zhang JY; Han J; Klonoff DC
    J Diabetes Sci Technol; 2020 Nov; 14(6):1035-1064. PubMed ID: 32985262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes.
    Ushigome E; Yamazaki M; Hamaguchi M; Ito T; Matsubara S; Tsuchido Y; Kasamatsu Y; Nakanishi M; Fujita N; Fukui M
    Diabetes Technol Ther; 2021 Jan; 23(1):78-80. PubMed ID: 32639844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.